Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
3 pending office actions • 2 art units • 2 examiners • 0 of 3 (0%) have an AI response strategy ready
Oragenics Inc. is currently managing 3 pending office actions within the Medical Devices & Mechanical Engineering technology area. These actions are distributed between 2 distinct examiners, which introduces variety in the examination styles the company must address. The prosecution activity is also spread across 2 distinct art units, indicating that the company's technology is being reviewed by two separate technical groups at the USPTO.
BAKSHI, PANCHAM is the busiest examiner for the portfolio, currently overseeing 2 pending office actions. This means that BAKSHI, PANCHAM is responsible for 2 of the 3 pending actions, while one other examiner handles the remaining matter. This concentration of work with a single examiner allows the company to develop a consistent relationship and understanding of that official's specific requirements.
The presence of 3 pending office actions across 2 examiners and 2 art units suggests a focused but active prosecution strategy in the Medical Devices & Mechanical Engineering sector. Practitioners should prioritize the interactions with BAKSHI, PANCHAM, given his significant role in the current docket. At the same time, they must ensure that the strategy for the third pending action remains aligned with the company's overall goals across both art units.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (67%) |
| §103 only | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BAKSHI, PANCHAM | 2 | 76.8% | +30.2% |
| HALL, DEANNA K | 1 | 75.7% | +15.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18702776 | BREATH-POWERED NASAL DEVICES FOR TREATMENT OF TRAUMATIC BRAIN INJURY (TBI), INCLUDING CONCUSSION, AND METHODS | HALL, DEANNA K | 215d overdue |
| 18653138 | C-20 STEROID COMPOUNDS, COMPOSITIONS AND USES THEREOF TO TREAT TRAUMATIC BRAIN INJURY (TBI), INCLUDING CONCUSSIONS | BAKSHI, PANCHAM | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18702776 | BREATH-POWERED NASAL DEVICES FOR TREATMENT OF TRAUMATIC BRAIN INJURY (TBI), INCLUDING CONCUSSION, AND METHODS | HALL, DEANNA K | 215d overdue |
| 18653138 | C-20 STEROID COMPOUNDS, COMPOSITIONS AND USES THEREOF TO TREAT TRAUMATIC BRAIN INJURY (TBI), INCLUDING CONCUSSIONS | BAKSHI, PANCHAM | — |
| 14857331 | C-20 STEROID COMPOUNDS, COMPOSITIONS AND USES THEREOF TO TREAT TRAUMATIC BRAIN INJURY (TBI), INCLUDING CONCUSSIONS | BAKSHI, PANCHAM | — |
| Art Unit | Apps |
|---|---|
| 3783 | 1 |
| 1623 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18653138 | C-20 STEROID COMPOUNDS, COMPOSITIONS AND USES THEREOF TO TREAT TRAUMATIC BRAIN INJURY (TBI), INCLUDING CONCUSSIONS | BAKSHI, PANCHAM | — | §101§102§103§112 | Non-Final OA | — | Pending | May 02, 2024 |
| 18702776 | BREATH-POWERED NASAL DEVICES FOR TREATMENT OF TRAUMATIC BRAIN INJURY (TBI), INCLUDING CONCUSSION, AND METHODS | HALL, DEANNA K | 3783 | §101§102§103 | Non-Final OA | 215d overdue | Pending | Apr 18, 2024 |
| 14857331 | C-20 STEROID COMPOUNDS, COMPOSITIONS AND USES THEREOF TO TREAT TRAUMATIC BRAIN INJURY (TBI), INCLUDING CONCUSSIONS | BAKSHI, PANCHAM | 1623 | §103 | Non-Final OA | — | Pending | Sep 17, 2015 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial